Apeng Liang

Title: Apeng Liang: Innovator in Neurodegenerative Disease Treatment

Introduction: Apeng Liang is a notable inventor based in Zhengzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurodegenerative diseases. His work focuses on creating effective treatments for conditions such as Alzheimer's disease.

Latest Patents: Apeng Liang holds 1 patent for a compound known as [1,3]thiazin-2-amine. This invention is directed towards a pharmaceutical composition that acts as a BACE inhibitor. The compound, represented by formula (I) or its pharmaceutically acceptable variants, demonstrates a strong inhibitory effect on BACE, making it a promising candidate for medicaments aimed at treating neurodegenerative diseases.

Career Highlights: Liang's career is marked by his dedication to pharmaceutical innovation. His work at Tetranov Pharmaceutical Co., Ltd. has positioned him as a key player in the development of new therapeutic agents. His research has the potential to significantly impact the treatment landscape for neurodegenerative diseases.

Collaborations: Apeng Liang collaborates with talented professionals in his field, including Yusheng Wu and Chengshan Niu. These partnerships enhance the research and development efforts at Tetranov Pharmaceutical Co., Ltd.

Conclusion: Apeng Liang's contributions to the field of pharmaceuticals, particularly in developing treatments for neurodegenerative diseases, highlight his innovative spirit and commitment to improving patient outcomes. His work continues to pave the way for advancements in medical science.